- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05626517
JARVISDHL Screening Tools
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Cardiovascular disease (CVD) is ranked 1st for mortality rate globally. In 2016, approximately 17.9 million people died from CVDs, representing 31% of all global deaths.
Retinal vasculature has been characterised as the 'window' to the body's circulatory system and been correlated with several diseases that perturbate systemic micro- and macro-vasculature such as hypertension, stroke and chronic kidney disease.
As microvascular changes often precede macrovascular changes, retinal imaging has the capability to be an easily available, non-invasive biomarker to screen for multiple vascular pathologies. A deep learning system (DLS) is a novel,state-of-art artificial intelligence (AI) technology that has achieved robust diagnostic performance for medical imaging analysis. The integration of deep learning (DL) into retinal image evaluation has accelerated its potential further. Its examination of fundus photographs has demonstrated abilities to detect several signs that are undetected by the human eye. With recent correlations being established between CAD and retinal vasculature aberrancies such as reduced calibres and fractal dimensions, there is a clear niche for AI to predict cardiac diseases with the use of retinal fundus photographs.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Weiting Huang
- Phone Number: 6704 8964 9637 0396
- Email: huang.weiting@singhealth.com.sg
Study Locations
-
-
-
Singapore, Singapore, 169609
- National Heart Centre Singapore
-
Contact:
- Weiting Huang
- Phone Number: 6704 8964 9637 0396
- Email: huang.weiting@singhealth.com.sg
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria for NHCS:
- 21 years of age or older
- Sufficient language skills in English or Chinese
- Provided informed consent
- Completed CTCA or CT CAC in the past 6 months.
Inclusion Criteria for SERI:
- 21 years of age or older
- Sufficient language skills in English or Chinese
- Provided informed consent
- Patient diagnosed with Diabetes for more than or equal to 10 years.
Exclusion Criteria for NHCS:
- Patients whose informed consent was not obtained.
- Age <21 years old
- Patients with cardiac event (acute myocardial infarction, Stroke, heart failure, angina requiring hospitalization) and/or coronary revascularization (percutaneous coronary intervention (PCI) and/or coronary artery bypass grafting (CABG) prior to CTCA
Exclusion Criteria in SERI:-
- Patient whose informed consent was not obtained.
- Age <21 years old
- Patients with cardiac event (acute myocardial infarction, Stroke, heart failure, angina requiring hospitalization) and/or coronary revascularization (percutaneous coronary intervention (PCI) and/or coronary artery bypass grafting (CABG) prior to CTCA
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
National Heart Centre Singapore
At NHCS, patients who have undergone either CTCA or CT CAC scan within past 6 months will be identified.
All the consented participants will have a one-off retinal imaging performed at the respective institution by the trained study team member, which should take approximately 15-20 minutes to complete.
3 to 4 questionnaires will also be administered (i.e.
EQ5D, International Index of Erectile Function, Pittsburgh Sleep Quality Index, General Questionnaire), depending patient's gender and literacy.
Only male patients who are literate in English language will be invited to complete the International Index of Erectile Function questionnaire.
Participants have the option to not complete sthe whole IIEF questionnaire or some of the questions if they are not comfortable with answering those questions.
|
The retinal photography will be acquired from macula-centre and an optic-disc centre for both left and right eye after their cardiac assessment.
Patient will be required to focus at a target inside the machine for approximately 5 to 10 seconds, with a flash followed at the end when eye image is captured.
Based on patients' eye conditions, additional or less images may be taken.
This allows a snapshot of both retinal and coronary vessels at a single point in time, no mydriatic drops will be used.
Participants will be given the option to undergo mydriatic photographs of the retina at SNEC/SERI depending on participant eye condition.
For mydriatic photograph, images will be obtained after pupil dilation and graded for presence and severity of diabetic retinopathy according to the modified ETDRS system and other retinal abnormalities by trained graders.
3 to 4 questionnaires will be administered (i.e.
EQ5D, International Index of Erectile Function, Pittsburgh Sleep Quality Index, General Questionnaire) to investigate the correlation between clinical characteristics, lifestyle (eg.
exercise, sleep, erectile dysfunction) and diet to retinal and coronary vasculature and outcomes.Only male patients who are literate in English language will be invited to complete the International Index of Erectile Function (IIEF) questionnaire.
Participants have the option to not complete the whole IIEF questionnaire or some of the questions if they are not comfortable with answering those questions.
|
Singapore Eye Research Institute
At SERI, patients who are found to be at high risk for vision threatening diabetic retinopathy will be identified.
All the consented participants will have a one-off retinal imaging performed at the respective institution by the trained study team member, which should take approximately 15-20 minutes to complete.
3 to 4 questionnaires will also be administered (i.e.
EQ5D, International Index of Erectile Function, Pittsburgh Sleep Quality Index, General Questionnaire), depending patient's gender and literacy.
Only male patients who are literate in English language will be invited to complete the International Index of Erectile Function questionnaire.
Participants have the option to not complete sthe whole IIEF questionnaire or some of the questions if they are not comfortable with answering those questions.
|
The retinal photography will be acquired from macula-centre and an optic-disc centre for both left and right eye after their cardiac assessment.
Patient will be required to focus at a target inside the machine for approximately 5 to 10 seconds, with a flash followed at the end when eye image is captured.
Based on patients' eye conditions, additional or less images may be taken.
This allows a snapshot of both retinal and coronary vessels at a single point in time, no mydriatic drops will be used.
Participants will be given the option to undergo mydriatic photographs of the retina at SNEC/SERI depending on participant eye condition.
For mydriatic photograph, images will be obtained after pupil dilation and graded for presence and severity of diabetic retinopathy according to the modified ETDRS system and other retinal abnormalities by trained graders.
3 to 4 questionnaires will be administered (i.e.
EQ5D, International Index of Erectile Function, Pittsburgh Sleep Quality Index, General Questionnaire) to investigate the correlation between clinical characteristics, lifestyle (eg.
exercise, sleep, erectile dysfunction) and diet to retinal and coronary vasculature and outcomes.Only male patients who are literate in English language will be invited to complete the International Index of Erectile Function (IIEF) questionnaire.
Participants have the option to not complete the whole IIEF questionnaire or some of the questions if they are not comfortable with answering those questions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
AI model and retinal imaging
Time Frame: Through study completion, an average of 2 years
|
This study will also expand the potential for AI models and retinal imaging as tools to identify systemic micro and macrovascular diseases such as hypertension, stroke and provide an easily available, risk-free tool for physicians to readily evaluate the state of the body's vessels.
|
Through study completion, an average of 2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
cross sectional performance of Cardiovascular risk stratification tool
Time Frame: Through study completion, an average of 2 years
|
Evaluate the cross sectional performance of Cardiovascular risk stratification tool, SIVA-DLS and Retina-CAC for cardiovascular risk stratification compared with patients undergoing cardiac CT scan.
Low risk is determined to be Agatston calcium score=0 and high risk being Agatston calcium score 100 and above.
|
Through study completion, an average of 2 years
|
longitudinal major cardiovascular event rate in subjects identified as high risk
Time Frame: Through study completion, an average of 2 years
|
Evaluate the longitudinal major cardiovascular event rate in subjects identified as high risk using a combination of cardiovascular risk stratification tool, SIVA DLS and Retina-CAC
|
Through study completion, an average of 2 years
|
major cardiovascular event rate in subjects identified as high risk
Time Frame: Through study completion, an average of 2 years
|
Evaluate if the major cardiovascular event rate in subjects identified as high risk and placed under medical intervention is lower compared to matched historical controls.
|
Through study completion, an average of 2 years
|
vision threatening retinopathy(VTDR) rate and rate of vision loss in subjects identified as high risk for VTDR
Time Frame: Through study completion, an average of 2 years
|
Evaluate if the vision threatening retinopathy(VTDR) rate and rate of vision loss in subjects identified as high risk for VTDR and placed in a VTDR clinic is lower compare to matched historical controls.
|
Through study completion, an average of 2 years
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Gavin Tan Siew Wei, Singapore National Eye Centre
- Principal Investigator: Weiting Huang, National Heart Centre Singapore
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R1869/111/2021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
-
Peking Union Medical College HospitalNot yet recruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
Peking Union Medical College HospitalRecruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
IGLESIAS Juan FernandoUniversity of BernNot yet recruiting
-
National Institutes of Health Clinical Center (CC)National Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Arteriosclerosis | Coronary Artery Disease (CAD) | Obstructive Coronary Artery DiseaseUnited States
-
Barts & The London NHS TrustImperial College London; Brunel UniversityNot yet recruitingCORONARY ARTERY DISEASE
-
Fundación EPICRecruitingCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery StenosisSpain
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Coronary Artery Stenosis | Coronary Artery RestenosisBelgium
-
China National Center for Cardiovascular DiseasesRecruitingLeft Main Coronary Artery DiseaseChina
Clinical Trials on Ocular Imaging
-
Medical University of ViennaRecruiting
-
Sun Yat-sen UniversityRecruitingImage, Body | Ophthalmological DisorderChina
-
Johns Hopkins UniversityCompleted
-
Insel Gruppe AG, University Hospital BernStiftung OPOS; Fondation BertarelliRecruiting
-
Alcon ResearchCompletedDry Eye DiseaseAustralia
-
University of Maryland, BaltimoreRecruiting
-
First Affiliated Hospital of Harbin Medical UniversityUnknown
-
First Affiliated Hospital of Harbin Medical UniversityUnknown
-
First Affiliated Hospital of Harbin Medical UniversityUnknown
-
Brighton and Sussex University Hospitals NHS TrustCompletedAge Related Macular Degeneration | Cataract Senile | Epiretinal Membrane | Vitreomacular Traction | Macula HoleUnited Kingdom